Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Constipation | 55 | 2024 | 563 | 8.000 |
Why?
|
Manometry | 40 | 2024 | 454 | 6.900 |
Why?
|
Gastroesophageal Reflux | 28 | 2023 | 821 | 5.280 |
Why?
|
Gastrointestinal Diseases | 34 | 2024 | 1201 | 4.390 |
Why?
|
Gastrointestinal Motility | 27 | 2024 | 233 | 4.330 |
Why?
|
Irritable Bowel Syndrome | 17 | 2024 | 452 | 3.870 |
Why?
|
Fecal Incontinence | 20 | 2024 | 242 | 3.690 |
Why?
|
Esophagus | 23 | 2020 | 1031 | 3.160 |
Why?
|
Abdominal Pain | 27 | 2024 | 1070 | 2.960 |
Why?
|
Esophageal Achalasia | 8 | 2022 | 94 | 2.910 |
Why?
|
Defecation | 16 | 2024 | 190 | 2.890 |
Why?
|
Esophageal pH Monitoring | 15 | 2022 | 203 | 2.640 |
Why?
|
Anal Canal | 16 | 2022 | 374 | 2.590 |
Why?
|
Eosinophilic Esophagitis | 11 | 2023 | 198 | 2.510 |
Why?
|
Electric Impedance | 20 | 2023 | 751 | 2.500 |
Why?
|
Hirschsprung Disease | 9 | 2024 | 163 | 2.000 |
Why?
|
Child | 176 | 2024 | 80079 | 1.680 |
Why?
|
Esophagitis | 13 | 2024 | 165 | 1.610 |
Why?
|
Rectum | 12 | 2022 | 891 | 1.600 |
Why?
|
Gastric Emptying | 9 | 2022 | 243 | 1.480 |
Why?
|
Bisacodyl | 5 | 2023 | 12 | 1.450 |
Why?
|
Fundoplication | 5 | 2022 | 144 | 1.320 |
Why?
|
Gastroenterology | 11 | 2024 | 577 | 1.280 |
Why?
|
Dyspepsia | 5 | 2024 | 116 | 1.210 |
Why?
|
Laxatives | 6 | 2021 | 92 | 1.200 |
Why?
|
Colon | 15 | 2023 | 1791 | 1.140 |
Why?
|
Capsule Endoscopy | 2 | 2020 | 102 | 1.140 |
Why?
|
Gastrointestinal Agents | 13 | 2024 | 510 | 1.070 |
Why?
|
Pressure | 6 | 2018 | 1150 | 1.010 |
Why?
|
Gastroparesis | 6 | 2022 | 138 | 1.000 |
Why?
|
Esophageal Motility Disorders | 4 | 2024 | 49 | 0.990 |
Why?
|
Adolescent | 115 | 2024 | 88234 | 0.980 |
Why?
|
Cough | 3 | 2014 | 595 | 0.960 |
Why?
|
Esophagitis, Peptic | 4 | 2010 | 76 | 0.950 |
Why?
|
Child, Preschool | 89 | 2024 | 42188 | 0.950 |
Why?
|
Eosinophilia | 9 | 2022 | 559 | 0.930 |
Why?
|
Gastrointestinal Transit | 5 | 2022 | 100 | 0.880 |
Why?
|
Enema | 5 | 2018 | 141 | 0.820 |
Why?
|
Bile Acids and Salts | 2 | 2021 | 393 | 0.810 |
Why?
|
Deglutition Disorders | 8 | 2015 | 626 | 0.800 |
Why?
|
Fecal Impaction | 4 | 2018 | 32 | 0.770 |
Why?
|
Hydrogen-Ion Concentration | 12 | 2016 | 2495 | 0.770 |
Why?
|
Duodenal Diseases | 2 | 2017 | 99 | 0.720 |
Why?
|
Colonic Diseases, Functional | 3 | 2023 | 39 | 0.710 |
Why?
|
Diagnostic Techniques, Digestive System | 3 | 2020 | 46 | 0.700 |
Why?
|
Jejunum | 2 | 2021 | 472 | 0.700 |
Why?
|
Cisapride | 6 | 2011 | 22 | 0.690 |
Why?
|
Domperidone | 1 | 2019 | 24 | 0.680 |
Why?
|
Neuromuscular Agents | 3 | 2012 | 148 | 0.680 |
Why?
|
Enteral Nutrition | 9 | 2024 | 794 | 0.680 |
Why?
|
Humans | 214 | 2024 | 760617 | 0.660 |
Why?
|
Benzofurans | 2 | 2021 | 139 | 0.640 |
Why?
|
Esophageal Sphincter, Lower | 2 | 2012 | 26 | 0.640 |
Why?
|
Peristalsis | 4 | 2024 | 60 | 0.630 |
Why?
|
Muscle Contraction | 4 | 2021 | 1200 | 0.620 |
Why?
|
Respiratory Sounds | 2 | 2013 | 702 | 0.600 |
Why?
|
Botulinum Toxins, Type A | 3 | 2012 | 238 | 0.600 |
Why?
|
Psychophysiologic Disorders | 1 | 2019 | 222 | 0.590 |
Why?
|
Muscle Relaxation | 4 | 2012 | 138 | 0.580 |
Why?
|
Reflex | 4 | 2022 | 375 | 0.580 |
Why?
|
Gastroenteritis | 1 | 2019 | 236 | 0.580 |
Why?
|
Esophagogastric Junction | 6 | 2024 | 347 | 0.580 |
Why?
|
Male | 134 | 2024 | 360358 | 0.580 |
Why?
|
Intestinal Pseudo-Obstruction | 3 | 2023 | 49 | 0.570 |
Why?
|
Female | 135 | 2024 | 392148 | 0.560 |
Why?
|
Infant | 50 | 2024 | 36152 | 0.560 |
Why?
|
Radiography, Abdominal | 3 | 2022 | 534 | 0.560 |
Why?
|
Gastric Acidity Determination | 4 | 2011 | 56 | 0.550 |
Why?
|
Feeding and Eating Disorders of Childhood | 1 | 2016 | 42 | 0.540 |
Why?
|
Urinary Tract Physiological Phenomena | 1 | 2016 | 11 | 0.540 |
Why?
|
Respiratory Tract Diseases | 3 | 2008 | 750 | 0.530 |
Why?
|
Quality of Life | 18 | 2024 | 13347 | 0.520 |
Why?
|
Propofol | 1 | 2022 | 602 | 0.510 |
Why?
|
Myoelectric Complex, Migrating | 3 | 2023 | 13 | 0.510 |
Why?
|
Receptors, IgE | 6 | 2020 | 375 | 0.500 |
Why?
|
Immunoglobulin E | 8 | 2020 | 1502 | 0.490 |
Why?
|
Serotonin 5-HT4 Receptor Agonists | 1 | 2014 | 11 | 0.490 |
Why?
|
Gastric Acid | 3 | 2016 | 99 | 0.490 |
Why?
|
Proton Pump Inhibitors | 4 | 2022 | 530 | 0.490 |
Why?
|
Stomach | 5 | 2017 | 695 | 0.480 |
Why?
|
Mucous Membrane | 3 | 2023 | 659 | 0.480 |
Why?
|
Vomiting | 6 | 2023 | 651 | 0.480 |
Why?
|
Encopresis | 3 | 2003 | 19 | 0.470 |
Why?
|
Breast Feeding | 2 | 2022 | 1354 | 0.460 |
Why?
|
Urodynamics | 1 | 2016 | 344 | 0.460 |
Why?
|
Botulinum Toxins | 3 | 2022 | 189 | 0.460 |
Why?
|
Diarrhea | 5 | 2024 | 1317 | 0.450 |
Why?
|
Cyproheptadine | 1 | 2013 | 20 | 0.440 |
Why?
|
Retrospective Studies | 46 | 2024 | 80566 | 0.420 |
Why?
|
Diagnosis, Differential | 18 | 2019 | 12966 | 0.410 |
Why?
|
Serotonin Antagonists | 1 | 2013 | 144 | 0.410 |
Why?
|
Hospital Costs | 2 | 2015 | 947 | 0.400 |
Why?
|
Pepsin A | 1 | 2011 | 66 | 0.390 |
Why?
|
Peptides | 4 | 2024 | 4354 | 0.390 |
Why?
|
Acalculous Cholecystitis | 2 | 2019 | 8 | 0.390 |
Why?
|
Prospective Studies | 31 | 2024 | 54360 | 0.390 |
Why?
|
Conscious Sedation | 1 | 2015 | 531 | 0.360 |
Why?
|
Duodenum | 4 | 2023 | 491 | 0.360 |
Why?
|
Short Bowel Syndrome | 3 | 2011 | 353 | 0.360 |
Why?
|
Upper Gastrointestinal Tract | 3 | 2023 | 46 | 0.360 |
Why?
|
Guideline Adherence | 2 | 2018 | 2218 | 0.360 |
Why?
|
Electrochemical Techniques | 1 | 2011 | 93 | 0.360 |
Why?
|
Treatment Outcome | 34 | 2024 | 64568 | 0.360 |
Why?
|
Esophageal Diseases | 1 | 2011 | 167 | 0.360 |
Why?
|
Oropharynx | 1 | 2011 | 138 | 0.350 |
Why?
|
Deglutition | 1 | 2012 | 208 | 0.350 |
Why?
|
Parasympatholytics | 1 | 2010 | 88 | 0.350 |
Why?
|
Mast Cells | 5 | 2020 | 1392 | 0.350 |
Why?
|
Langerhans Cells | 1 | 2010 | 170 | 0.340 |
Why?
|
Rectal Diseases | 2 | 2009 | 142 | 0.340 |
Why?
|
Gyrus Cinguli | 1 | 2016 | 1115 | 0.340 |
Why?
|
Food Hypersensitivity | 4 | 2020 | 726 | 0.340 |
Why?
|
Urinary Bladder | 1 | 2016 | 1151 | 0.330 |
Why?
|
Quality Improvement | 2 | 2022 | 3797 | 0.320 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2011 | 755 | 0.320 |
Why?
|
Neural Pathways | 2 | 2018 | 3056 | 0.320 |
Why?
|
Feces | 4 | 2021 | 1490 | 0.320 |
Why?
|
Spinal Cord Diseases | 1 | 2011 | 291 | 0.310 |
Why?
|
Parents | 12 | 2021 | 3563 | 0.310 |
Why?
|
Insurance, Health | 1 | 2021 | 2495 | 0.310 |
Why?
|
RNA, Messenger | 6 | 2018 | 12758 | 0.310 |
Why?
|
Health Expenditures | 1 | 2021 | 2361 | 0.310 |
Why?
|
Enterocolitis | 2 | 2024 | 106 | 0.300 |
Why?
|
Radionuclide Imaging | 3 | 2020 | 1972 | 0.290 |
Why?
|
Physicians | 2 | 2019 | 4583 | 0.290 |
Why?
|
Polyethylene Glycols | 3 | 2011 | 1182 | 0.290 |
Why?
|
Postoperative Complications | 5 | 2024 | 15612 | 0.280 |
Why?
|
Severity of Illness Index | 17 | 2024 | 15828 | 0.280 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3194 | 0.280 |
Why?
|
Receptors, Fc | 1 | 2010 | 534 | 0.280 |
Why?
|
Chronic Disease | 13 | 2023 | 9311 | 0.280 |
Why?
|
Pediatrics | 5 | 2020 | 3588 | 0.270 |
Why?
|
X-Rays | 2 | 2022 | 307 | 0.270 |
Why?
|
Urinary Incontinence | 1 | 2011 | 489 | 0.270 |
Why?
|
Pylorus | 2 | 2020 | 86 | 0.270 |
Why?
|
Octreotide | 2 | 2016 | 154 | 0.270 |
Why?
|
Health Communication | 2 | 2021 | 212 | 0.270 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8516 | 0.270 |
Why?
|
Double-Blind Method | 11 | 2024 | 12334 | 0.260 |
Why?
|
Postprandial Period | 3 | 2016 | 314 | 0.260 |
Why?
|
Toilet Training | 2 | 2003 | 18 | 0.260 |
Why?
|
Naltrexone | 1 | 2008 | 317 | 0.250 |
Why?
|
Prefrontal Cortex | 1 | 2016 | 2219 | 0.250 |
Why?
|
Macrophages, Alveolar | 1 | 2008 | 411 | 0.250 |
Why?
|
Pelvic Floor | 2 | 2020 | 138 | 0.250 |
Why?
|
Crohn Disease | 2 | 2016 | 2279 | 0.230 |
Why?
|
Diet | 2 | 2022 | 8048 | 0.230 |
Why?
|
Gallbladder Emptying | 1 | 2003 | 14 | 0.230 |
Why?
|
Corn Oil | 1 | 2003 | 28 | 0.220 |
Why?
|
Psyllium | 1 | 2023 | 2 | 0.220 |
Why?
|
Digestive System Surgical Procedures | 1 | 2009 | 571 | 0.220 |
Why?
|
Narcotic Antagonists | 1 | 2008 | 585 | 0.220 |
Why?
|
Anxiety | 7 | 2024 | 4570 | 0.210 |
Why?
|
Case-Control Studies | 12 | 2018 | 22148 | 0.210 |
Why?
|
Attitude of Health Personnel | 2 | 2021 | 3879 | 0.210 |
Why?
|
Sensitivity and Specificity | 9 | 2019 | 14648 | 0.210 |
Why?
|
Monitoring, Physiologic | 3 | 2006 | 1779 | 0.200 |
Why?
|
Intestinal Atresia | 2 | 2011 | 68 | 0.200 |
Why?
|
Monosaccharides | 1 | 2022 | 66 | 0.200 |
Why?
|
Attitude to Health | 3 | 2015 | 2024 | 0.200 |
Why?
|
Quarantine | 1 | 2024 | 182 | 0.200 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2003 | 1116 | 0.190 |
Why?
|
Ileostomy | 1 | 2022 | 121 | 0.190 |
Why?
|
Disaccharides | 1 | 2022 | 170 | 0.190 |
Why?
|
Sacrum | 1 | 2003 | 274 | 0.190 |
Why?
|
Spinal Cord | 2 | 2011 | 1807 | 0.190 |
Why?
|
Meningomyelocele | 1 | 2022 | 171 | 0.190 |
Why?
|
Young Adult | 15 | 2024 | 59179 | 0.190 |
Why?
|
Brain Mapping | 1 | 2016 | 6634 | 0.180 |
Why?
|
Enteritis | 1 | 2022 | 162 | 0.180 |
Why?
|
Urinary Bladder Diseases | 1 | 2021 | 167 | 0.180 |
Why?
|
Food, Formulated | 2 | 1998 | 100 | 0.180 |
Why?
|
Nausea | 2 | 2022 | 679 | 0.170 |
Why?
|
Melanosis | 1 | 2021 | 93 | 0.170 |
Why?
|
Dermatitis, Atopic | 2 | 2019 | 731 | 0.170 |
Why?
|
Gene Expression Profiling | 2 | 2015 | 9417 | 0.170 |
Why?
|
Gastritis | 1 | 2022 | 199 | 0.170 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5776 | 0.170 |
Why?
|
Cost of Illness | 3 | 2021 | 1935 | 0.170 |
Why?
|
Follow-Up Studies | 15 | 2024 | 39063 | 0.170 |
Why?
|
Colonic Diseases | 1 | 2021 | 201 | 0.170 |
Why?
|
Gastrostomy | 2 | 2003 | 323 | 0.170 |
Why?
|
Colonoscopy | 3 | 2018 | 1396 | 0.170 |
Why?
|
Omeprazole | 1 | 2020 | 105 | 0.170 |
Why?
|
Lipid Metabolism | 1 | 2008 | 1896 | 0.170 |
Why?
|
Allergens | 4 | 2020 | 1429 | 0.160 |
Why?
|
Neurotoxins | 1 | 2020 | 240 | 0.160 |
Why?
|
Endoscopy | 3 | 2020 | 1851 | 0.160 |
Why?
|
Barium Sulfate | 4 | 2000 | 180 | 0.160 |
Why?
|
Cecostomy | 1 | 2018 | 10 | 0.160 |
Why?
|
Colitis | 3 | 2008 | 1234 | 0.160 |
Why?
|
Awards and Prizes | 1 | 2023 | 360 | 0.160 |
Why?
|
Pyloric Antrum | 1 | 2018 | 66 | 0.160 |
Why?
|
Dumping Syndrome | 1 | 1998 | 18 | 0.160 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2022 | 872 | 0.150 |
Why?
|
Esophageal Atresia | 1 | 2021 | 225 | 0.150 |
Why?
|
Referral and Consultation | 3 | 2015 | 3599 | 0.150 |
Why?
|
Starch | 1 | 1998 | 79 | 0.150 |
Why?
|
Reference Values | 5 | 2020 | 4919 | 0.150 |
Why?
|
Vasoactive Intestinal Peptide | 2 | 1989 | 179 | 0.150 |
Why?
|
Muscle, Smooth | 4 | 2009 | 927 | 0.150 |
Why?
|
Milk Hypersensitivity | 1 | 1999 | 82 | 0.150 |
Why?
|
Cathartics | 3 | 2012 | 127 | 0.150 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2017 | 2423 | 0.150 |
Why?
|
Gallbladder Diseases | 1 | 2019 | 140 | 0.150 |
Why?
|
Thoracoscopy | 1 | 2018 | 180 | 0.140 |
Why?
|
Radiography | 7 | 2004 | 6961 | 0.140 |
Why?
|
Eosinophils | 4 | 2013 | 953 | 0.140 |
Why?
|
Consensus | 4 | 2022 | 3117 | 0.140 |
Why?
|
Infant, Newborn | 11 | 2023 | 26180 | 0.140 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2022 | 664 | 0.140 |
Why?
|
Physician-Patient Relations | 2 | 2021 | 3239 | 0.140 |
Why?
|
Laryngoscopy | 1 | 2022 | 707 | 0.140 |
Why?
|
Adult | 23 | 2024 | 220969 | 0.140 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2017 | 161 | 0.140 |
Why?
|
Hospitalization | 2 | 2024 | 10704 | 0.140 |
Why?
|
Amitriptyline | 3 | 2014 | 112 | 0.130 |
Why?
|
Tooth Erosion | 1 | 2016 | 9 | 0.130 |
Why?
|
Cross-Sectional Studies | 6 | 2021 | 26049 | 0.130 |
Why?
|
Cattle | 1 | 2022 | 3841 | 0.130 |
Why?
|
Pain Measurement | 3 | 2023 | 3546 | 0.130 |
Why?
|
Biopsy | 5 | 2017 | 6762 | 0.130 |
Why?
|
Child Nutrition Disorders | 1 | 1997 | 139 | 0.130 |
Why?
|
Fibroblast Growth Factors | 1 | 2021 | 865 | 0.130 |
Why?
|
Age Factors | 7 | 2015 | 18381 | 0.130 |
Why?
|
Phytotherapy | 1 | 1997 | 296 | 0.120 |
Why?
|
Barrett Esophagus | 1 | 1999 | 492 | 0.120 |
Why?
|
Watchful Waiting | 1 | 2019 | 491 | 0.120 |
Why?
|
Chickens | 1 | 1997 | 858 | 0.120 |
Why?
|
Bronchoscopy | 2 | 2013 | 909 | 0.120 |
Why?
|
Medicine | 1 | 2023 | 942 | 0.120 |
Why?
|
Ectodermal Dysplasia | 2 | 2008 | 106 | 0.120 |
Why?
|
Brain Diseases | 1 | 2024 | 1545 | 0.120 |
Why?
|
Urination Disorders | 1 | 2016 | 238 | 0.120 |
Why?
|
Interleukin-10 | 1 | 2020 | 1172 | 0.120 |
Why?
|
Boston | 3 | 2017 | 9313 | 0.120 |
Why?
|
Chi-Square Distribution | 3 | 2009 | 3410 | 0.120 |
Why?
|
Meat | 1 | 1997 | 584 | 0.120 |
Why?
|
Tooth | 1 | 2016 | 210 | 0.120 |
Why?
|
Algorithms | 5 | 2019 | 14018 | 0.120 |
Why?
|
Stomach Diseases | 1 | 2015 | 134 | 0.120 |
Why?
|
Practice Guidelines as Topic | 5 | 2018 | 7389 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2021 | 1250 | 0.110 |
Why?
|
Hematoma | 1 | 1998 | 762 | 0.110 |
Why?
|
Time Factors | 8 | 2021 | 39913 | 0.110 |
Why?
|
Basophils | 1 | 2016 | 407 | 0.110 |
Why?
|
Perception | 1 | 2020 | 1198 | 0.110 |
Why?
|
Receptors, Scavenger | 1 | 2014 | 123 | 0.110 |
Why?
|
Posture | 2 | 2011 | 956 | 0.110 |
Why?
|
Analysis of Variance | 4 | 2012 | 6224 | 0.110 |
Why?
|
Outpatient Clinics, Hospital | 2 | 2015 | 393 | 0.110 |
Why?
|
Th2 Cells | 1 | 2018 | 1056 | 0.110 |
Why?
|
Antigens, CD1d | 1 | 2014 | 228 | 0.110 |
Why?
|
Depression | 1 | 2013 | 8132 | 0.110 |
Why?
|
Spinal Dysraphism | 1 | 2015 | 178 | 0.110 |
Why?
|
Lung | 1 | 2011 | 9998 | 0.110 |
Why?
|
Diet Therapy | 1 | 2014 | 151 | 0.100 |
Why?
|
Education, Medical, Continuing | 1 | 2018 | 823 | 0.100 |
Why?
|
Hospitals, Pediatric | 3 | 2011 | 1859 | 0.100 |
Why?
|
Intestines | 2 | 2016 | 1909 | 0.100 |
Why?
|
Circadian Rhythm | 1 | 2004 | 2569 | 0.100 |
Why?
|
ROC Curve | 2 | 2010 | 3575 | 0.100 |
Why?
|
Chemokines, CXC | 1 | 2014 | 416 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2024 | 10754 | 0.100 |
Why?
|
Analgesics, Opioid | 1 | 2008 | 3805 | 0.100 |
Why?
|
Endoscopy, Digestive System | 1 | 2014 | 352 | 0.090 |
Why?
|
Glutathione Transferase | 1 | 2013 | 565 | 0.090 |
Why?
|
Ostomy | 1 | 2011 | 33 | 0.090 |
Why?
|
Bronchoalveolar Lavage | 1 | 2011 | 129 | 0.090 |
Why?
|
Lymphocytes | 1 | 2019 | 2604 | 0.090 |
Why?
|
Catheterization | 2 | 2018 | 1428 | 0.090 |
Why?
|
Surgical Stomas | 1 | 2011 | 42 | 0.090 |
Why?
|
Injections, Intralesional | 1 | 2012 | 280 | 0.090 |
Why?
|
Research Design | 2 | 2022 | 6174 | 0.090 |
Why?
|
Postoperative Care | 1 | 2017 | 1467 | 0.090 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2650 | 0.090 |
Why?
|
Prevalence | 6 | 2022 | 15689 | 0.090 |
Why?
|
Predictive Value of Tests | 6 | 2019 | 15251 | 0.090 |
Why?
|
Supine Position | 1 | 2011 | 205 | 0.090 |
Why?
|
Natural Killer T-Cells | 1 | 2014 | 322 | 0.090 |
Why?
|
Esophagoscopy | 3 | 2008 | 397 | 0.090 |
Why?
|
Health Care Surveys | 1 | 2017 | 2423 | 0.090 |
Why?
|
Gastroscopy | 1 | 2012 | 211 | 0.090 |
Why?
|
Analgesics, Non-Narcotic | 2 | 2014 | 370 | 0.090 |
Why?
|
Electrolytes | 1 | 2011 | 274 | 0.090 |
Why?
|
Critical Illness | 3 | 2020 | 2709 | 0.090 |
Why?
|
Prone Position | 1 | 2011 | 196 | 0.090 |
Why?
|
Injections, Intramuscular | 2 | 2009 | 555 | 0.080 |
Why?
|
Gastrointestinal Tract | 1 | 2016 | 833 | 0.080 |
Why?
|
Gallbladder | 2 | 2019 | 308 | 0.080 |
Why?
|
Urination | 1 | 2011 | 201 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2022 | 2238 | 0.080 |
Why?
|
Peptide PHI | 1 | 1989 | 4 | 0.080 |
Why?
|
Myasthenic Syndromes, Congenital | 1 | 2009 | 17 | 0.080 |
Why?
|
I-kappa B Kinase | 2 | 2008 | 249 | 0.080 |
Why?
|
Decision Trees | 1 | 2011 | 504 | 0.080 |
Why?
|
Emergency Service, Hospital | 2 | 2022 | 7871 | 0.080 |
Why?
|
Reproducibility of Results | 8 | 2023 | 20074 | 0.080 |
Why?
|
Receptors, Gastrointestinal Hormone | 1 | 1989 | 39 | 0.080 |
Why?
|
Pain | 2 | 2017 | 5061 | 0.080 |
Why?
|
Cholecystectomy | 2 | 2019 | 406 | 0.080 |
Why?
|
Choline O-Acetyltransferase | 1 | 2009 | 156 | 0.080 |
Why?
|
Sodium Chloride | 1 | 2011 | 586 | 0.080 |
Why?
|
Neuropeptide Y | 1 | 1990 | 192 | 0.080 |
Why?
|
Self Report | 3 | 2016 | 3723 | 0.080 |
Why?
|
Blood Cells | 1 | 2010 | 305 | 0.080 |
Why?
|
Decision Support Systems, Clinical | 1 | 2017 | 1167 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 3031 | 0.070 |
Why?
|
Societies, Medical | 4 | 2024 | 3900 | 0.070 |
Why?
|
Diffusion Tensor Imaging | 1 | 2018 | 2400 | 0.070 |
Why?
|
Apnea | 1 | 2009 | 195 | 0.070 |
Why?
|
Syndrome | 1 | 2014 | 3268 | 0.070 |
Why?
|
Decision Support Techniques | 1 | 2017 | 1998 | 0.070 |
Why?
|
Brain | 3 | 2024 | 27101 | 0.070 |
Why?
|
Comorbidity | 3 | 2015 | 10505 | 0.070 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2008 | 202 | 0.070 |
Why?
|
Medication Adherence | 2 | 2017 | 2174 | 0.070 |
Why?
|
Constriction, Pathologic | 1 | 2011 | 1096 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3800 | 0.070 |
Why?
|
Hematologic Diseases | 1 | 2011 | 496 | 0.070 |
Why?
|
Piperidines | 1 | 1996 | 1655 | 0.070 |
Why?
|
Remission Induction | 1 | 2013 | 2391 | 0.070 |
Why?
|
North America | 2 | 2021 | 1273 | 0.070 |
Why?
|
Activities of Daily Living | 2 | 2014 | 2417 | 0.070 |
Why?
|
Medical Staff, Hospital | 1 | 2011 | 601 | 0.070 |
Why?
|
Laparoscopy | 1 | 2018 | 2030 | 0.070 |
Why?
|
Dietary Fiber | 2 | 2023 | 758 | 0.070 |
Why?
|
Acetaminophen | 2 | 2024 | 555 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2021 | 4007 | 0.070 |
Why?
|
Cell Count | 1 | 2010 | 1835 | 0.070 |
Why?
|
Disability Evaluation | 1 | 2014 | 1835 | 0.070 |
Why?
|
Cerebral Palsy | 1 | 2011 | 474 | 0.070 |
Why?
|
Inflammation | 3 | 2022 | 10760 | 0.070 |
Why?
|
Patient Satisfaction | 2 | 2021 | 3451 | 0.070 |
Why?
|
Obesity | 2 | 2009 | 12933 | 0.070 |
Why?
|
Animals | 13 | 2022 | 168201 | 0.070 |
Why?
|
Complementary Therapies | 1 | 2010 | 486 | 0.070 |
Why?
|
Mental Recall | 1 | 2012 | 1222 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 3527 | 0.060 |
Why?
|
Health Surveys | 2 | 2018 | 4037 | 0.060 |
Why?
|
Clinical Competence | 2 | 2021 | 4789 | 0.060 |
Why?
|
Medical Records | 1 | 2011 | 1407 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2020 | 4947 | 0.060 |
Why?
|
Colitis, Ulcerative | 2 | 2016 | 1921 | 0.060 |
Why?
|
Opossums | 3 | 1990 | 104 | 0.060 |
Why?
|
Length of Stay | 2 | 2018 | 6418 | 0.060 |
Why?
|
Energy Intake | 2 | 2011 | 2132 | 0.060 |
Why?
|
United States | 9 | 2024 | 72272 | 0.060 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2008 | 547 | 0.060 |
Why?
|
Food | 2 | 2020 | 768 | 0.060 |
Why?
|
Gene Expression | 2 | 2017 | 7568 | 0.060 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2008 | 386 | 0.060 |
Why?
|
Parenteral Nutrition | 2 | 2024 | 659 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 4 | 2016 | 36402 | 0.060 |
Why?
|
Observer Variation | 1 | 2010 | 2606 | 0.060 |
Why?
|
Tetrodotoxin | 3 | 1990 | 245 | 0.060 |
Why?
|
Psychometrics | 3 | 2021 | 3060 | 0.050 |
Why?
|
Metabolomics | 1 | 2013 | 1656 | 0.050 |
Why?
|
Propionates | 1 | 2004 | 183 | 0.050 |
Why?
|
Factor Analysis, Statistical | 2 | 2017 | 997 | 0.050 |
Why?
|
Recovery of Function | 1 | 2013 | 2978 | 0.050 |
Why?
|
Baclofen | 1 | 2003 | 120 | 0.050 |
Why?
|
Mitochondrial Encephalomyopathies | 1 | 2002 | 40 | 0.050 |
Why?
|
Probability | 1 | 2008 | 2475 | 0.050 |
Why?
|
Hypohidrosis | 1 | 2002 | 29 | 0.050 |
Why?
|
Intestine, Small | 2 | 2023 | 1207 | 0.050 |
Why?
|
Treatment Failure | 1 | 2008 | 2635 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12043 | 0.050 |
Why?
|
Endosonography | 2 | 2003 | 608 | 0.050 |
Why?
|
Biofeedback, Psychology | 2 | 2000 | 116 | 0.050 |
Why?
|
Time | 1 | 2003 | 545 | 0.050 |
Why?
|
Hernia, Hiatal | 1 | 2002 | 90 | 0.050 |
Why?
|
Esophageal Neoplasms | 1 | 2011 | 1653 | 0.050 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 2004 | 283 | 0.050 |
Why?
|
Swine | 2 | 2009 | 5907 | 0.050 |
Why?
|
Anaphylaxis | 2 | 2019 | 757 | 0.050 |
Why?
|
Cheese | 1 | 2020 | 38 | 0.050 |
Why?
|
Prognosis | 5 | 2018 | 29600 | 0.050 |
Why?
|
Patient Compliance | 1 | 2011 | 2688 | 0.050 |
Why?
|
Glycine | 1 | 2004 | 661 | 0.050 |
Why?
|
Androstadienes | 1 | 2002 | 348 | 0.040 |
Why?
|
Parenteral Nutrition, Total | 2 | 2016 | 304 | 0.040 |
Why?
|
Gene Expression Regulation | 3 | 2013 | 11874 | 0.040 |
Why?
|
Surface-Active Agents | 1 | 2000 | 150 | 0.040 |
Why?
|
Neurologic Examination | 1 | 2003 | 915 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 1989 | 2802 | 0.040 |
Why?
|
Eggs | 1 | 2020 | 182 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2020 | 18221 | 0.040 |
Why?
|
Mitochondrial Diseases | 1 | 2003 | 343 | 0.040 |
Why?
|
Intubation, Gastrointestinal | 1 | 2020 | 165 | 0.040 |
Why?
|
Cell Degranulation | 1 | 2020 | 277 | 0.040 |
Why?
|
Haptoglobins | 1 | 2020 | 165 | 0.040 |
Why?
|
Rotation | 1 | 2001 | 517 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2019 | 6188 | 0.040 |
Why?
|
Glutathione | 1 | 2001 | 582 | 0.040 |
Why?
|
Primary Health Care | 1 | 2015 | 4668 | 0.040 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2000 | 361 | 0.040 |
Why?
|
Age of Onset | 2 | 2017 | 3302 | 0.040 |
Why?
|
Urinary Bladder, Neurogenic | 1 | 1979 | 173 | 0.040 |
Why?
|
Biliary Tract | 1 | 2019 | 135 | 0.040 |
Why?
|
Attitude | 1 | 2003 | 772 | 0.040 |
Why?
|
Communication Barriers | 1 | 2021 | 414 | 0.040 |
Why?
|
Absorption | 1 | 1997 | 242 | 0.040 |
Why?
|
Rehydration Solutions | 1 | 1997 | 43 | 0.040 |
Why?
|
Food Additives | 1 | 1997 | 23 | 0.040 |
Why?
|
Delphi Technique | 1 | 2021 | 846 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3413 | 0.040 |
Why?
|
Acute Disease | 2 | 1998 | 7237 | 0.040 |
Why?
|
Risk Factors | 3 | 2015 | 74115 | 0.040 |
Why?
|
Pharmacogenetics | 1 | 2021 | 675 | 0.040 |
Why?
|
Injections | 1 | 2020 | 832 | 0.040 |
Why?
|
Decision Making | 1 | 2011 | 3918 | 0.040 |
Why?
|
Wiskott-Aldrich Syndrome | 1 | 2017 | 131 | 0.030 |
Why?
|
Gastrointestinal Contents | 1 | 2017 | 42 | 0.030 |
Why?
|
Sex Factors | 1 | 2011 | 10548 | 0.030 |
Why?
|
Dilatation | 1 | 2018 | 306 | 0.030 |
Why?
|
Interleukin-13 | 1 | 2019 | 392 | 0.030 |
Why?
|
Family Conflict | 1 | 2017 | 95 | 0.030 |
Why?
|
Organic Chemicals | 1 | 1997 | 210 | 0.030 |
Why?
|
Receptors, Interleukin-1 Type I | 1 | 2016 | 30 | 0.030 |
Why?
|
Cysteine | 1 | 2001 | 891 | 0.030 |
Why?
|
Suction | 1 | 2017 | 266 | 0.030 |
Why?
|
Logistic Models | 3 | 2014 | 13245 | 0.030 |
Why?
|
Protein Precursors | 1 | 2020 | 1131 | 0.030 |
Why?
|
Milk | 1 | 1999 | 442 | 0.030 |
Why?
|
Comprehension | 1 | 2021 | 620 | 0.030 |
Why?
|
Contrast Media | 2 | 1999 | 5305 | 0.030 |
Why?
|
Health Literacy | 1 | 2021 | 443 | 0.030 |
Why?
|
Medical History Taking | 1 | 1999 | 773 | 0.030 |
Why?
|
Causality | 1 | 2002 | 1240 | 0.030 |
Why?
|
Physician Assistants | 1 | 2018 | 190 | 0.030 |
Why?
|
Permeability | 1 | 1997 | 721 | 0.030 |
Why?
|
Placebos | 1 | 2000 | 1667 | 0.030 |
Why?
|
Cohort Studies | 3 | 2018 | 41457 | 0.030 |
Why?
|
Incidence | 3 | 2018 | 21337 | 0.030 |
Why?
|
Interleukin-4 | 1 | 2019 | 1146 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2021 | 846 | 0.030 |
Why?
|
Respiration, Artificial | 2 | 2017 | 2630 | 0.030 |
Why?
|
Nurse Practitioners | 1 | 2018 | 269 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 1998 | 1178 | 0.030 |
Why?
|
Vitamin A | 1 | 1997 | 612 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2011 | 9172 | 0.030 |
Why?
|
Nutritive Value | 1 | 1997 | 347 | 0.030 |
Why?
|
Ovalbumin | 1 | 2016 | 675 | 0.030 |
Why?
|
Interleukins | 1 | 2019 | 783 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 1997 | 726 | 0.030 |
Why?
|
Dairy Products | 1 | 1997 | 490 | 0.030 |
Why?
|
Phenotype | 3 | 2017 | 16571 | 0.030 |
Why?
|
Sickness Impact Profile | 1 | 2015 | 299 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2017 | 1575 | 0.030 |
Why?
|
Caregivers | 2 | 2017 | 2241 | 0.030 |
Why?
|
Electric Stimulation | 2 | 1990 | 1734 | 0.030 |
Why?
|
Physical Examination | 1 | 1999 | 1254 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 10199 | 0.030 |
Why?
|
Autoantibodies | 1 | 2022 | 2115 | 0.030 |
Why?
|
Immunization | 1 | 2017 | 1217 | 0.030 |
Why?
|
Pilot Projects | 2 | 2020 | 8618 | 0.030 |
Why?
|
Pandemics | 2 | 2024 | 8645 | 0.030 |
Why?
|
Ambulatory Care | 1 | 2004 | 2768 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 1635 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2018 | 969 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2002 | 1810 | 0.030 |
Why?
|
Disease Outbreaks | 1 | 2021 | 1748 | 0.020 |
Why?
|
Cytokines | 2 | 2020 | 7373 | 0.020 |
Why?
|
Needs Assessment | 1 | 2018 | 1139 | 0.020 |
Why?
|
Proctocolectomy, Restorative | 1 | 1994 | 190 | 0.020 |
Why?
|
Interleukin-23 | 1 | 2013 | 201 | 0.020 |
Why?
|
Physicians, Primary Care | 1 | 2018 | 617 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2601 | 0.020 |
Why?
|
Fasting | 1 | 1997 | 1603 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2014 | 943 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2021 | 1418 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1884 | 0.020 |
Why?
|
Body Mass Index | 1 | 2009 | 12943 | 0.020 |
Why?
|
Blood Transfusion | 1 | 1998 | 1299 | 0.020 |
Why?
|
Citrulline | 1 | 2011 | 106 | 0.020 |
Why?
|
Child Health Services | 1 | 2016 | 644 | 0.020 |
Why?
|
Eating | 1 | 1997 | 1535 | 0.020 |
Why?
|
Chemotaxis | 1 | 2014 | 598 | 0.020 |
Why?
|
Folic Acid | 1 | 1997 | 1323 | 0.020 |
Why?
|
Antibody Affinity | 1 | 2011 | 246 | 0.020 |
Why?
|
Abdomen | 1 | 2017 | 1128 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 3016 | 0.020 |
Why?
|
Guanethidine | 1 | 1990 | 13 | 0.020 |
Why?
|
Pyrilamine | 1 | 1990 | 13 | 0.020 |
Why?
|
Methysergide | 1 | 1990 | 28 | 0.020 |
Why?
|
Gastroschisis | 1 | 2011 | 99 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2008 | 5672 | 0.020 |
Why?
|
Up-Regulation | 2 | 2014 | 4117 | 0.020 |
Why?
|
Recurrence | 2 | 2003 | 8426 | 0.020 |
Why?
|
Lumbosacral Plexus | 1 | 1990 | 54 | 0.020 |
Why?
|
Pyridostigmine Bromide | 1 | 2009 | 32 | 0.020 |
Why?
|
Atropine | 1 | 1990 | 244 | 0.020 |
Why?
|
Receptors, Vasoactive Intestinal Peptide | 1 | 1989 | 9 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2015 | 909 | 0.020 |
Why?
|
Indomethacin | 1 | 1990 | 323 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2013 | 982 | 0.020 |
Why?
|
Tachyphylaxis | 1 | 1989 | 54 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2019 | 10432 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2017 | 11069 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2002 | 3232 | 0.020 |
Why?
|
Immunoblotting | 1 | 2011 | 1646 | 0.020 |
Why?
|
Blepharoptosis | 1 | 2009 | 144 | 0.020 |
Why?
|
Reference Standards | 1 | 2011 | 1002 | 0.020 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2003 | 3612 | 0.020 |
Why?
|
Midazolam | 1 | 2009 | 266 | 0.020 |
Why?
|
Mice | 3 | 2020 | 81368 | 0.020 |
Why?
|
Cholinesterase Inhibitors | 1 | 2009 | 242 | 0.020 |
Why?
|
Odds Ratio | 1 | 2000 | 9643 | 0.020 |
Why?
|
Health Personnel | 1 | 2021 | 3333 | 0.020 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2011 | 326 | 0.020 |
Why?
|
Curriculum | 1 | 2021 | 3738 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 1999 | 3680 | 0.020 |
Why?
|
Risk | 1 | 1999 | 9604 | 0.020 |
Why?
|
Naloxone | 1 | 1990 | 370 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6338 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2015 | 1375 | 0.020 |
Why?
|
Sepsis | 1 | 2001 | 2585 | 0.020 |
Why?
|
K562 Cells | 1 | 2008 | 641 | 0.020 |
Why?
|
Growth Hormone-Releasing Hormone | 1 | 1988 | 128 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 12978 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 17878 | 0.020 |
Why?
|
Energy Metabolism | 1 | 1997 | 2878 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5200 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5866 | 0.020 |
Why?
|
Middle Aged | 3 | 2024 | 220584 | 0.020 |
Why?
|
Signal Transduction | 2 | 2020 | 23416 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2011 | 1697 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2009 | 1162 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2013 | 2189 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2014 | 1661 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4473 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2000 | 12447 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2008 | 575 | 0.020 |
Why?
|
Senna Extract | 1 | 2004 | 3 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2009 | 13441 | 0.010 |
Why?
|
Siblings | 1 | 2008 | 824 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2020 | 18937 | 0.010 |
Why?
|
Thioguanine | 1 | 2003 | 45 | 0.010 |
Why?
|
Telemedicine | 1 | 2021 | 3050 | 0.010 |
Why?
|
Leukemic Infiltration | 1 | 2003 | 47 | 0.010 |
Why?
|
Daunorubicin | 1 | 2003 | 157 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2014 | 5239 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2016 | 9529 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2009 | 17629 | 0.010 |
Why?
|
Internet | 1 | 2015 | 3090 | 0.010 |
Why?
|
Sigmoidoscopy | 1 | 2003 | 151 | 0.010 |
Why?
|
Ammonia | 1 | 2004 | 237 | 0.010 |
Why?
|
Critical Care | 1 | 2015 | 2690 | 0.010 |
Why?
|
Carnitine | 1 | 2004 | 252 | 0.010 |
Why?
|
Respiration | 1 | 2009 | 1656 | 0.010 |
Why?
|
Mutation | 2 | 2009 | 30016 | 0.010 |
Why?
|
Surgical Stapling | 1 | 2003 | 98 | 0.010 |
Why?
|
Mesentery | 1 | 2003 | 202 | 0.010 |
Why?
|
Etoposide | 1 | 2003 | 634 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14389 | 0.010 |
Why?
|
Patient Discharge | 1 | 2015 | 3442 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6520 | 0.010 |
Why?
|
Cytarabine | 1 | 2003 | 697 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8207 | 0.010 |
Why?
|
Pedigree | 1 | 2009 | 4539 | 0.010 |
Why?
|
Dilatation, Pathologic | 1 | 2003 | 527 | 0.010 |
Why?
|
Health Status | 1 | 2014 | 4075 | 0.010 |
Why?
|
Hypnotics and Sedatives | 1 | 2009 | 1178 | 0.010 |
Why?
|
Ubiquinone | 1 | 2002 | 183 | 0.010 |
Why?
|
Blood Glucose | 1 | 2015 | 6390 | 0.010 |
Why?
|
Monocytes | 1 | 2010 | 2565 | 0.010 |
Why?
|
Calorimetry, Indirect | 1 | 2001 | 174 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22115 | 0.010 |
Why?
|
Funnel Chest | 1 | 1981 | 74 | 0.010 |
Why?
|
Peroxidase | 1 | 2003 | 610 | 0.010 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2001 | 353 | 0.010 |
Why?
|
Sternum | 1 | 1981 | 175 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2008 | 4804 | 0.010 |
Why?
|
Antigens, CD1 | 1 | 2002 | 439 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 2003 | 982 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2002 | 20556 | 0.010 |
Why?
|
Urinary Diversion | 1 | 1979 | 134 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2014 | 4488 | 0.010 |
Why?
|
Urinary Catheterization | 1 | 1979 | 193 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9345 | 0.010 |
Why?
|
Spain | 1 | 1979 | 487 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2005 | 1528 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2014 | 14591 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2002 | 1865 | 0.010 |
Why?
|
Medicare | 1 | 2015 | 6765 | 0.010 |
Why?
|
Models, Animal | 1 | 2003 | 2109 | 0.010 |
Why?
|
Dexamethasone | 1 | 2003 | 1947 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2002 | 1887 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2008 | 4745 | 0.010 |
Why?
|
Vitamins | 1 | 2002 | 1635 | 0.010 |
Why?
|
NF-kappa B | 1 | 2002 | 2481 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 2002 | 2191 | 0.010 |
Why?
|
Adenomatous Polyposis Coli | 1 | 1994 | 218 | 0.010 |
Why?
|
Models, Genetic | 1 | 2002 | 3431 | 0.010 |
Why?
|
Phosphorylation | 1 | 2002 | 8311 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2015 | 58894 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2002 | 10175 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 11736 | 0.000 |
Why?
|
Aged | 1 | 2015 | 169042 | 0.000 |
Why?
|
Osteotomy | 1 | 1981 | 836 | 0.000 |
Why?
|